News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

One step means less paperwork for cholesterol drug

8 August 2005

One step means less paperwork for cholesterol drug

Government drug-funder PHARMAC is giving patients easier long-term access to the cholesterol-lowering drug atorvastatin (Lipitor) and reducing the workload of clinicians in the process.

From 1 September people will be able to have a lifetime Special Authority approval for atorvastatin at first application, rather than having to make two applications as at present. Current criteria require patients to have a 12-week trial before a second application is made.

Special Authority is a targeting mechanism to help ensure medicines are used by people who meet specific funding criteria.

Chief Executive Wayne McNee says the change is another way in which PHARMAC is responding to issues that have been raised by clinicians about paperwork.

“We have reviewed the prescribing data which shows that about 95 percent of patients go through both stages of the approval process,” Wayne McNee says. “This suggests there is little need for having a 12-week trial period, and that clinicians are very good at accurately identifying patients who meet the access criteria.

“There will be an increase in the number of patients who receive atorvastatin as a result of this change. Another benefit will be that there will be a reduction in the cost of blood tests, which are required at both the first and second applications. Now just one set of blood tests will be required.”

Currently about 25,000 people are prescribed atorvastatin, representing about 10 percent of all patients prescribed a cholesterol-lowering statin.

PHARMAC estimates the change could see patient numbers increase by about 5 percent.

ENDS

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Reuben Moss' Property is Theft! & Kaitani at The Physics Room

Property is Theft! continues Moss’ interest in the contemporary urban environment as a space controlled by pulsing and unequal flows of capital and labour. Kaitani features work by the University of Canterbury Fijian Students Association and Kulimoe’anga Stone Maka. More>>


Handcrafted Form: Rare Treasures From Japan

This unique exhibition at Expressions Whirinaki represents 90 everyday objects made by contemporary Japanese artisans who employ various traditional craft techniques made in regional workshops. The works used in daily life are crafted from raw materials with techniques appropriate to bringing out the best of its medium, balancing ease of use with aesthetic appeal. More>>

Howard Davis Article: A Musical Axis - Brahms, Wagner, Sibelius

Brahms' warm and exquisitely subtle Symphony No. 3 in F major, Wagner's irrepressibly sentimental symphonic poem Siegfried Idyll, and Sibelius' chilling and immensely challenging Violin Concerto in D minor exemplify distinct stages of development in a tangled and convoluted series of skirmishes that came to define subsequent disputes about the nature of post-Romantic orchestral writing well into the following century. More>>

Scoop Review Of Books: A Pale Ghost Writer

Reviewed by Ruth Brassington, Richard Flanagan's new novel is about a novelist hastily ghost-writing the biography of a crook about to go to trial. The reader is kept on a cliff-edge, as the narrator tries to get blood out of his stone man. More>>

New Zealand Wars Commemoration: Witi Ihimaera's Sleeps Standing Moetū

The second of several articles to mark Rā Maumahara, remembering the New Zealand Land Wars. The first was a Q&A with Vincent O’Malley, author of The Great War for New Zealand: Waikato 1800–2000. More>>

ALSO:

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland